Cytotoxicity, mutagenicity, and tumorigenicity of mainstream smoke from three reference cigarettes machine-smoked to the same yields of total particulate matter per cigarette

Food and Chemical Toxicology

Volumn 47, Issue 8, 2009, Pages 1810-1818

  Roemer, E ^a   Ottmueller, T H ^b   Zenzen, V ^b   Wittke, S ^b   Radtke, F ^b   Blanco, I ^c   Carchman, R A ^d  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Philip Morris Research Laboratories GmbH   (Germany)

^c VIVOTECNIA   (Spain)

^d NONE   (United States)

Author keywords

Cigarette mainstream smoke; Cytotoxicity; Mutagenicity; Skin painting; Smoking regimen; Tumorigenicity

Indexed keywords

CIGARETTE SMOKE;

AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTAGENICITY; NONHUMAN; PARTICULATE MATTER; SALMONELLA TYPHIMURIUM; TATTOOING;

3T3 CELLS; ANIMALS; CARCINOGENS; CELL SURVIVAL; MICE; MICE, INBRED SENCAR; MUTAGENICITY TESTS; MUTAGENS; NEOPLASMS; PARTICULATE MATTER; REFERENCE STANDARDS; SKIN NEOPLASMS; SMOKE; TOBACCO;

MUS; SALMONELLA TYPHIMURIUM;

EID: 68649086379     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.04.048     Document Type: Article

References (52)

1. Armitage P. Multistage models of carcinogenesis. Environ. Health Perspect. 63 (1985) 195-201
2. Babich H., and Borenfreund E. Cytotoxic and morphological effects of phenylpropanolamine, caffeine, nicotine, and some of their metabolites studied in vitro. Toxicol. In Vitro 6 (1992) 493-502
3. Baker R.R. Smoke generation inside a burning cigarette: modifying combustion to develop cigarettes that may be less hazardous to health. Progr. Energy Combust. Sci. 32 (2006) 373-385
4. Baker R.R., Massey E.D., and Smith G. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42S (2004) S53-S83
5. Bartecchi C.E., MacKenzie T.D., and Schrier R.W. The human cost of tobacco use (1). N. Engl. J. Med. 330 (1994) 907-912
6. Bernstein L., Kaldor J., McCann J., and Pike M.C. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat. Res. 97 (1982) 267-281
7. Borenfreund E., and Puerner J.A. Toxicity determined in vitro by morphological alterations and Neutral Red absorption. Toxicol. Lett. 24 (1985) 119-124
8. Boutwell R.K. The function and mechanism of promoters of carcinogenesis. Crit. Rev. Toxicol. 2 (1974) 419-443
9. Bridges R.B., Combs J.G., Humble J.W., Turbeck J.A., Rehm S.R., and Haley N.J. Puffing topography as a determinant of smoke exposure. Pharmacol. Biochem. Behav. 37 (1990) 29-39
10. Chepiga T.A., Morton M.J., Murphy P.A., Avalos J.T., Bombick B.R., Doolittle D.J., Bogerding M.F., and Swauger J.E. A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). Food Chem. Toxicol. 38 (2000) 949-962
11. Coggins C.R.E., Haroz R.K., Lam R., and Morgan K.T. The tumorigenicity of smoke condensates from cigarettes containing different amounts of Cytrel assessed by mouse skin painting. Toxicology 23 (1982) 177-185
12. Counts M.E., Morton M.J., Laffoon S.W., Cox R.H., and Lipowicz P.J. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regul. Toxicol. Pharmacol. 41 (2005) 185-227
13. Counts M.E., Hsu F.S., and Tewes F.J. Development of a commercial "market map" comparison methodology for evaluating new or non-conventional cigarettes. Regul. Toxicol. Pharmacol. 46 (2006) 225-242
14. DeMarini D.M., Ramadevi G., Szudlinska A., Rao M., Recio L., Kehl M., Kirby P.E., Polzin G., and Richter P.A. Genotoxicity of 10 cigarette smoke condensates in four test systems: comparisons between assays and condensates. Genet. Toxicol. Environ. Mutagen. 650 (2008) 15-29
15. DeMarini D.M., Ramadevi G., Szudlinska A., Rao M., Recio L., Kehl M., Kirby P.E., Polzin G., and Richter P.A. Genotoxicity of 10 cigarette smoke condensates in four test systems: comparisons between assays and condensates - Corrigendum. Mutat. Res. 652 (2008) 208
16. Diana J.N., and Vaught A. Research Cigarettes (1980), The University of Kentucky Printing Services, Lexington KY
17. EEC, European Economic Community, 2003. Directive 2003/65/EEC on the Protection of Animals used for Experimental and other Scientific Purposes.
18. Foy J.W., Bombick B.R., Bombick D.W., Doolittle D.J., Mosberg A.T., and Swauger J.E. A comparison of in vitro toxicities of cigarette smoke condensate from Eclipse cigarettes and four commercially available ultra low-"tar" cigarettes. Food Chem. Toxicol. 42 (2004) 237-243
19. Gaworski C.L., Heck J.D., Bennett M.B., and Wenk M.L. Toxicologic evaluation of flavor ingredients added to cigarette tobacco: skin painting bioassay of cigarette smoke condensate in SENCAR mice. Toxicology 139 (1999) 1-17
20. Hammond D., Fong G.T., Cummings K.M., O'Connor R.J., Giovino G.A., and McNeill A. Cigarette yields and human exposure: a comparison of alternative testing regimens. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 1495-1501
21. Hammond D., Wiebel F., Kozlowski L.T., Borland R., Cummings K.M., O'Connor R.J., McNeill A., Connolly G.N., Arnott D., and Fong G.T. Revising the machine smoking regime for cigarette emissions: implications for tobacco control policy. Tob. Control 16 (2007) 8-14
22. Höfer I., Nil R., and Bättig K. Ultralow-yield cigarettes and type of ventilation: the role of ventilation blocking. Pharmacol. Biochem. Behav. 40 (1991) 907-914
23. IARC, International Agency for Research on Cancer. Biological data relevant to the carcinogenic risk in humans. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans - Tobacco Smoking vol. 38 (1986), IARC Press, Lyon 127-198
24. INVITTOX. INVITTOX Protocol 3a, The FRAME Modified Neutral Red Uptake Cytotoxicity Test (1990), INVITTOX, Nottingham, UK
25. ISO, International Standard Organization, 1991. Guideline 4387, Determination of Total and Nicotine-free Dry Particulate Matter using Routine Analytical Smoking Machine.
26. Kaiserman M.J., and Rickert W.S. Carcinogens in tobacco smoke: benzo(a)pyrene from Canadian cigarettes and cigarette tobacco. Am. J. Public Health 82 (1992) 1023-1026
27. Kozlowski L.T., and O'Connor R.J. Official cigarette tests are misleading: use a two-stage, compensating test. Lancet 355 (2000) 2159-2161
28. Lu B., Kerepesi L., Wisse L., Hitchman K., and Meng Q.R. Cytotoxicity and gene expression profiles in cell cultures exposed to whole smoke from three types of cigarettes. Toxicol. Sci. 98 (2007) 469-478
29. Lubin J.H., and Caporaso N.E. Cigarette smoking and lung cancer: modelling total exposure and intensity. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 517-523
30. MacKenzie T.D., Bartecchi C.E., and Schrier R.W. The human cost of tobacco use (2). N. Engl. J. Med. 330 (1994) 975-980
31. Maron D.M., and Ames B.N. Reviewed methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
32. Norman A. Cigarette design and materials. In: Davis D.L., and Nielsen M.T. (Eds). Tobacco, Production, Chemistry and Technology (1999), Blackwell, Science, Oxford, UK 353-387
33. OECD, Organization for Economic Cooperation and Development. Guideline 471, bacterial reverse mutation test. OECD Guidelines for Testing of Chemicals (1997), OECD, Paris, France
34. Peeler, C.L., 1996. Cigarette testing and the federal trade commission: a historical overview. In: Report of the NCI Expert Committee, US Department of Health and Human Services, Public Health Service (Eds.), Smoking and Tobacco Control. Monograph 7. The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of US Cigarettes. National Institute of Health, Bethesda, MD.
35. Putnam K.P., Bombick D.W., and Doolittle D.J. Evaluation of eight in vitro assays for assessing the cytotoxicity of cigarette smoke condensate. Toxicol. In Vitro 16 (2002) 599-607
36. Radtke, F., Schmickler, M., Ochel, W., Schaffernicht, H., 2007. European Patent EP1832745 (A1) 2007.
37. Rickert W.S., Trivedi A.H., Momin R.A., Wright W.G., and Lauterbach J.H. Effect of smoking conditions and methods of collection on the mutagenicity and cytotoxicity of cigarette mainstream smoke. Toxicol. Sci. 96 (2007) 285-293
38. Roemer E., and Hackenberg U. Mouse skin bioassay of smoke condensates from cigarettes containing different levels of cocoa. Food Addit. Contam. 7 (1990) 563-569
39. Roemer E., Tewes F.J., Meisgen T.J., Veltel D.J., and Carmines E.L. Evaluation of the potential effects of ingredients added to cigarettes. Part 3: In vitro genotoxicity and cytotoxicity. Food Chem. Toxicol. 40 (2002) 105-111
40. Roemer E., Stabbert R., Rustemeier K., Veltel D.J., Meisgen T.J., Reininghaus W., Carchman R.A., Gaworski C.L., and Podraza K.F. Chemical composition, cytotoxicity, and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195 (2004) 31-52
41. Scherer G. Smoking behaviour and compensation: a review of the literature. Psychopharmacology (Berl.) 145 (1999) 1-20
42. Schorp, M.K., 2005. Summary of literature data on smoking topography. In: A Review of Human Smoking Behaviour Data and Recommendations for a New ISO Standard for the Machine Smoking of Cigarettes. Report of the AD HOC WG9 Smoking Behaviour Review Team to ISO/TC 126 WG 9. Retrieved at: (Bates-No. 551963717).
43. Schramke H., Meisgen T.J., Tewes F.J., Gomm W., and Roemer E. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 227 (2006) 193-210
44. Shibuya K., Inoue M., and Lopez A.D. Statistical modeling and projections of lung cancer mortality in 4 industrialized countries. Int. J. Cancer 117 (2005) 476-485
45. Steele R.H., Payne V.M., Fulp C.W., Rees D.C., Lee C.K., and Doolittle D.J. A comparison of the mutagenicity of mainstream cigarette smoke condensate from a representative sample of the US cigarette commercial with a Kentucky reference cigarette (K1R4F). Mutat. Res. 342 (1995) 179-190
46. Surgeon General. The Health Consequences of Smoking: A Report of the Surgeon General, Atlanta, Georgia (2004), US Department of Health and Human Services, Centers for Disease Control and Prevention, Office on Smoking and Health
47. TRC, Tobacco Research Council. Review of Activities, 1970-1974 (1975), T&A Constable Ltd., Edinburgh pp. 26-27
48. UKCCCR. United Kingdom Co-ordinating committee on cancer research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia. Br. J. Cancer 77 2 (1998) 1-10
49. US CPSC, United States Consumer Products Safety Commission, 1993. United States Consumer Products Safety Commission in Consultation with the US Department of Health and Human Services. Toxicity Testing Plan 5.
50. US DHHS, United States Department of Health and Human Services, 2001. Smoking and Tobacco Control. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. Public Health Services, National Institutes of Health, National Cancer Institute, Bethesda, MD, USA.
51. US EPA, United States Environmental Protection Agency, 2000. Supplementary Guidance for Conducting Health Risk Assessment of Chemical Mixtures. EPA/630/R-00/002. Risk Assessment Forum US EPA, Washington, DC 20460.
52. Walaszek Z., Hanausek M., and Slaga T.J. The role of skin painting in predicting lung cancer. Int. J. Toxicol. 26 (2007) 345-351